文章摘要
Xiaoying Quan,Xiaoyan Chen,Lei Lei,Xiaoli Jia,Chunzhi Wu,Bin Ye. Case report of a mixed pulmonary large cell neuroendocrine carcinoma. Oncol Transl Med, 2022, 8: 311-313.
复合型肺大细胞神经内分泌癌1例
Case report of a mixed pulmonary large cell neuroendocrine carcinoma
Received:January 17, 2022  Revised:December 20, 2022
DOI:10.1007/s10330-022-0554-4
中文关键词: 肺大细胞神经内分泌癌;肺腺癌;诊断;治疗
英文关键词: pulmonary large cell neuroendocrine carcinoma; pulmonary adenocarcinoma; diagnosis; treatment
基金项目:
Author NameAffiliationE-mail
Xiaoying Quan Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu 1193084163@qq.com 
Xiaoyan Chen Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu  
Lei Lei Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu  
Xiaoli Jia Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu  
Chunzhi Wu Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu  
Bin Ye* Department of Medical Oncology, The Sixth People''''s Hospital of Chengdu 354539616@qq.com 
Hits: 3599
Download times: 4210
中文摘要:
  1例57岁男性患者体检CT发现右肺中叶肿物,纤支镜活检示查见肿瘤细胞,行手术切除。术后病理为复合型肺大细胞神经内分泌癌,基因检测EGFR 21外显子L858R突变。术后行6周期依托泊苷联合顺铂化疗,化疗结束后予奥西替尼靶向治疗。随访至今,患者未见肿瘤复发转移征象。
英文摘要:
    A 57 year-old male patient was found to have a lesion in the middle lobe of his right lung using chest computed tomography (CT). Tumor cells were detected, and surgical excision was performed. The patient was diagnosed with mixed large cell neuroendocrine carcinoma, and underwent six cycles of a chemotherapy regimen comprising etoposide combined with cisplatin. Genetic testing revealed an EGFR mutation, which prompted oxitinib-targeted therapy. To date, no signs of recurrence or metastasis have been reported.
View Full Text   Download reader  HTML全文
Close